Back to Directory
GeneFirst
South East England
Founded 2011
Multiplex PCR and NGS diagnostics for cancer and infection
GeneFirst is a molecular diagnostics company developing multiplex PCR assays and next-generation sequencing technologies for cancer screening, precision oncology and infectious disease testing.
Its Papilloplex assays detect high-risk human papillomavirus DNA or E6/E7 mRNA. The XCeloSeq platform provides library preparation for low-input and challenging clinical samples, while other assays detect respiratory pathogens and rare mutations.
In June 2026, its high-risk HPV DNA and mRNA kits received regulatory approval in Thailand.